Japanese Pharmaceutical Company Touts Ivermectin’s ‘Antiviral Effect’ Against COVID-19

  • by:
  • 03/02/2023

Japanese trading and pharmaceutical company Kowa Co. Ltd. said Monday that ivermectin shows an “antiviral effect” against the omicron variant and others. 

The statement was based on joint, non-clinical trials the company has been running with Tokyo’s Kitasato University, Just the News reports

It is no secret that the drug is extremely controversial. It is not approved for use in treating the virus in Japan, and in the U.S., the FDA continues to caution against its use. 

While the FDA argues there have been a number of cases in which people were hospitalized after self-medicating with the drug, there have also been several cases of it being used to successfully treat COVID-19 in unvaccinated and vaccinated patients. 

Ivermectin is currently being studied in the United Kingdom in a trial through Oxford University. 

Image: by is licensed under

Opinion

View All

Ukraine suffers 'significant losses' as long-awaited counteroffensive begins against Russian forces: US officials

Ukrainian forces have been met with strong resistance from Russian soldiers after attempting to penet...

Elderly UK woman dies after being assaulted by man in hospital bathroom

A woman in Ipswich died after she was knocked to the floor by another hospital patient who reportedly...

CCP building massive eavesdropping facility near Cuba

China is prepared to erect an electronic spy facility in Cuba, which will be just 100 miles from the ...

NICOLE RUSSELL: Glamour UK is NOT breaking barriers by featuring a pregnant cover model who thinks she's a man

"It took me ages to get to this point of being confident of who I am now, in being a pregnant man."...

© 2023 Human Events, Privacy Policy